Document:

Exhibit
10(o)(vi)

 

[As
amended August 7, 2003]

 

 

DIRECTORS ANNUAL RETAINER
PLAN

 

 

1.             This
Plan shall govern the annual retainer payable for services as a member of the
Board of Directors of Albany International Corp. (“the Company”) during the
period from the Annual Meeting of Stockholders of the Company in 2001 until it
is amended or terminated by the Board of Directors; provided, that in no event
shall any shares be paid under this plan after May 14, 2006.  This Plan shall affect only the portion of
the annual retainer to be paid in shares of Class A Common Stock of the
Company.

 

2.             A
portion of the annual retainer payable for service as a member of the Board of
Directors each year shall be paid in shares of Class A Common Stock of the
Company. The number of shares to be paid each year shall be determined by
dividing $10,000 by the per share closing price of a share of such stock on the
day of the Annual Meeting at which the election of directors for such year
occurs (“the Valuation Price”), as such Valuation Price is shown on the
composite index for such day in the Wall Street Journal, rounded down to the
nearest whole number.

 

3.             The
shares of Class A Common Stock payable to a director as part of the annual
retainer shall be delivered to the director as promptly as practicable after
each Annual Meeting. Upon delivery to the director, such shares shall be fully
paid, non-assessable and not subject to forfeiture.

 

4.             The
portion of the annual retainer not paid in shares –– that is the aggregate
dollar amount of the annual retainer for the year, as determined from time to
time by the Board of Directors, less (i) the Valuation Price times (ii) the
number of whole shares payable to a director for the year –– shall be paid to
the directors in cash at such time or times during the year as the Board of
Directors shall from time to time determine.

 

5.             This
Plan may be terminated or amended by the Board of Directors at any time.Exhibit 10.1

 

	
  DynPort
  Vaccine Company LLC

  	
   

  	
  Subcontractor Service Agreement No. DPSC02-02257

  

 

 

SUBCONTRACTOR SERVICE AGREEMENT NO.
DPSC02-02257

 

This is a Time and Materials
(T&M) SUBCONTRACTOR SERVICE AGREEMENT (hereinafter referred to as
“Agreement”) by and between DynPort Vaccine Company LLC (hereinafter referred
to as “DVC”), a Virginia corporation, and AVANT Immunotherapeutics, Inc.
(hereinafter referred to as “Subcontractor”), hereinafter referred to jointly
as  “the
Parties”.

 

Whereas, Subcontractor is, by reason of
knowledge, education, and/or experience, capable of performing and desires to
perform services for DVC in support of the U.S. Department of Defense Joint
Vaccine Acquisition Program (JVAP) under U.S. Government Contract No.
DAMD17-98-C-8024.

 

In consideration of the promises, mutual
covenants, and agreements contained herein, the parties agree as follows:

 

1.                                      General Terms and Conditions

The general conditions set forth in
Attachment A, General Terms and Conditions, are incorporated herein.

 

2.                                      Scope of Work

Subject to the terms and conditions of this
Agreement, the Subcontractor will furnish the services described in Attachment
B, Statement of Work.

 

3.                                      Term

This Agreement shall be effective for the
period December 31, 2002 through December 31, 2003, in accordance with
Attachment C, Performance Schedule.  DVC
may immediately terminate in the event of the Subcontractor’s breach of this
Agreement, or if DVC’s prime contractual support for the Subcontractor is
terminated.  DVC reserves the right to
extend the term of this Agreement upon written notification to, and mutual
agreement of, the Subcontractor.

 

4.                                      Authorized Funding

a.               This
Agreement has an authorized funded value of $2,726,076.72, in accordance with
Attachment D, Price Schedule.  This
value represents the maximum amount the Subcontractor is currently authorized
to expend in performance of the work authorized hereunder.

b.              Subcontractor
shall notify DVC’s Subcontract Administrator, in writing, if Subcontractor
believes that the costs which will become due to Subcontractor in the next
sixty (60) days, when added to all other costs previously accrued, will exceed
seventy-five percent (75%) of the authorized funding.  That notice shall include an estimate of additional funds
required.  Subcontractor is not
obligated to perform any work, and DVC is not obligated to reimburse
Subcontractor for any work performed, if in performing that work Subcontractor
exceeds the authorized funding.

c.               DVC
reserves the right to change the authorized funded value of this Agreement if:

•                  The Defense
Contract Audit Agency (DCAA), following review of the Subcontractor indirect
rates (Fringe, Overhead, and G&A) authorized hereunder, determines that
those rates are unacceptable and must be modified.

•                  Such change is
deemed necessary by DVC to ensure the fairness and reasonableness of the
authorized funded value of this Agreement.

d.              As required, the authorized funded value
of this Agreement will be changed by issuance of bilateral modification(s) to
this Agreement.  The authorized funded
value of this Agreement shall not exceed the maximum agreement value (ceiling
value).

 

5.                                      Maximum Agreement Value (Ceiling Value)

The maximum value of this Agreement (ceiling value) shall not exceed
$2,726,076.72.  If Subcontractor, at any
time during the performance of the work authorized hereunder, has reason to
believe that the ceiling value specified herein will be insufficient to
complete the work, Subcontractor shall notify DVC immediately, advising the
reason(s) for such cost increase and providing a revised cost estimate with
supporting cost justification.  The
ceiling value indicated herein shall not be exceeded without DVC’s prior
written approval.

 

 

6.              Options

 

a.               DVC may, at its sole discretion,
authorize Subcontractor to perform the following optional tasks, as presented
in Subcontractor’s original quotation, dated August 22, 2002, submitted in
response to DVC Request for Quotation (RFQ) No. RQ02257:

•                  Task 3.2 – Develop Production Processes for
Live Bacterial Vector Vaccines

•                  Task 3.3 – Develop Formulations and
Preservation Methods for Live Bacterial Vector Vaccines

•                  Task 3.5 – Demonstrate the Efficacy of Live
Bacterial Vector Vaccines

b.              DVC reserves the right to require
Subcontractor to submit updated quotations for the tasks presented in Paragraph
6a above prior to their award to Subcontractor.

c.               The options presented in Paragraph 6a above
will be exercised solely at the discretion of DVC.

d.              The authorized funded and ceiling values of
this Agreement will be modified as required to incorporate the addition of
optional tasks.

e.               As required, the authorized funded and
ceiling values of this Agreement will be changed by issuance of bilateral
modification(s) to this Agreement.  The
authorized funded value of this Agreement shall not exceed the maximum
agreement value (ceiling value).

 

7.                                      Direction

The Subcontractor shall be responsible for
its performance. The DVC Senior Scientist, Dr. Barbara Solow, shall provide technical direction and clarification
regarding the scope of work.  The DVC
Subcontract Administrator, Roy Conley, is solely responsible for
changes/modifications to the scope, schedule, and budget of this
Agreement.  No employment relationship
between DVC and Subcontractor or its employees, Subcontractors, or agents shall
be created by this Agreement.

 

8.                                      Consideration and Payment

a.               As consideration for services to be provided
here under, DVC will compensate Subcontractor per Attachment D, Price Schedule.

b.              All invoices shall be signed and dated by
the Subcontractor and must reference this Agreement number and the following
Contract Work Breakdown Structure (CWBS) numbers as appropriate, depending upon
the task performed:

•                  CWBS No. C.5.9.2.1:
Construct Live Bacterial Vectors Using Genetically Engineered Strains of V.
cholerae, S. typhi, or S. typhimurium

•                  CWBS No. C.5.9.2.2:
Clone Heterologous Antigens PA, F1, and V Into hlyA, inp, and/or Chromosomal
Insertion Plasmids

•                  CWBS No. C.5.9.2.3:
Construct
Live Bacterial Vector Strains Expressing Single Heterologous Antigens and/or
Combinations of Antigens

•                  CWBS No. C.5.9.2.4:
Develop Methods to Quantify the Expression of PA and/or F1 and V Localized in
Cytoplasmic and Extra-Cytoplasmic Compartments of Live Bacterial Vectors

•                  CWBS No. C.5.9.2.5:
Determine
the Expression Level of PA, F1, and V in Live Bacterial Vector Strains

•                  CWBS No. C.5.9.2.6:
Develop
Methods to Analyze the Biophysical Characteristics of PA and/or F1 and V, and
Analyze the Integrity and Cellular Localization of the Respective Antigens

•                  CWBS No. C.5.9.2.7:
Construct
Research Cell Banks of the Live Bacterial Vector Strains and Characterize the
Cell Banks Using Appropriate Test Methods

•                  CWBS No. C.5.9.2.8:
Project Managment

 

c.               Invoices shall be due and payable within
thirty (30) days after receipt of an acceptable invoice and certification of
the labor hours worked and purchases made. 
Invoices shall be submitted, in duplicate, to:

 

DynPort Vaccine Company LLC

Attn.: Accounts Payable

64 Thomas Johnson Drive

Frederick, MD 21702

Telephone:            (301) 607-5000

Fax:                                                 (301) 607-5068

 

Such invoice shall, at a minimum, include the
following information and provide the information shown on Exhibit 1, Sample
T&M Invoice:

 

•                  Seller’s name and business address;

•                  Date of invoice;

•                  Period covered by invoice;

•                  This Agreement number;

•                  Applicable CWBS number;

 

2

 

•                  Total number of hours worked rate per hour,
total labor charges, and total of all labor charges;

•                  Charges for authorized materials, services,
or travel; and

•                  Subcontractor’s signature.

d.              Invoices shall be signed by a company
officer or other responsible, authorized person and contain the following
certification: “I certify to the best of my knowledge and belief that the above
request for payment is true and correct; that the charges are fair and
reasonable; and that the proposed request includes only allowable and allocable
charges.”

e.               Subcontractor will use its best efforts to
include charges on invoices no later than sixty (60) days after occurrence.

f.                 All invoices are subject to audit by the
Government for completeness and accuracy and for allowability of costs pursuant
to Federal Acquisition Regulation (FAR) Part 31.  DVC will pay only those costs ultimately determined to be
allowable.

 

9.                                      Allowable
Charges

Payment to the Subcontractor for the
performance of services hereunder shall be as follows:

a.               DVC shall
compensate the Subcontractor for authorized work performed to address the
technical intent of the Statement of Work herein, at the T&M authorized
funding specified above.

 

10.                               Security Requirements

The Subcontractor may be required to certify
that it has read and shall comply with all applicable project security
requirements and that the Subcontractor has received the security clearance
required for performance of the work authorized by this Agreement.  If applicable, such security clearance shall
remain in effect during the term of this Agreement and FAR Clause 52.204-2,
Security Requirement, shall be incorporated into this Agreement by reference.  Such certification shall be documented on a
Training Certification issued to, and executed by, the Subcontractor before
work is initiated.

 

11.                               Agreement Supersedence

This Agreement may be
superseded in its entirety by a Task Order to be issued following execution of
a Basic Ordering Agreement (BOA) between DVC and Subcontractor.

 

12.                               Defense Priorities and Allocations System (DPAS) Rating

This Agreement is assigned a
DPAS rating of DO-C9 and contains rated order quantities certified for national
defense use.  The Subcontractor is
required to follow all of the provisions of the Defense Priorities and
Allocations System regulation (15 CFR Part 700) only as it pertains to the
rated quantities.

 

13.                               Flowdown Clauses

a.               The clauses in
Attachment F, FAR and Defense Federal Acquisition Regulation Supplement (DFARS)
Flowdown Clauses, are incorporated herein by reference.

b.              Throughout this Agreement, wherever the
following words are used in FAR/DFARS references, substitute the following:

 

	
  Government
  Term

  	
   

  	
  Substitute

  
	
  Contract

  	
   

  	
  Agreement

  
	
  Contractor

  	
   

  	
  Subcontractor

  
	
  Subcontractor

  	
   

  	
  Lower-tier Subcontractor

  
	
  Government

  	
   

  	
  DynPort Vaccine Company LLC

  
	
  Contracting Officer

  	
   

  	
  DynPort Vaccine Company LLC Subcontract Representative or designee

  
	
  COTR

  	
   

  	
  DynPort Vaccine Company LLC Technical
  Representative or designee

  

 

14.                               FAR/DFARS Clauses Incorporated in Full Text

The
following FAR/DFARS clauses are incorporated herein in full text:

 

52.203-11                Certification and
Disclosure Regarding Payments to Influence Certain Federal Transactions (APR
1991)

(a)          The definitions and
prohibitions contained in the clause, at FAR 52.203-12, Limitation on Payments
to Influence Certain Federal Transactions, included in this solicitation, are
hereby incorporated by reference in paragraph (b) of this certification.

(b)         The offeror, by signing its
offer, hereby certifies to the best of his or her knowledge and belief that on
or after December 23, 1989 ––

(1)          No Federal appropriated funds have been paid or will be paid to any
person for influencing or attempting to influence an officer or employee of any
agency, a Member of Congress, an officer or employee of Congress, or an
employee of a Member of Congress on his or her behalf in connection with the
awarding of any Federal contract, the making of any Federal grant, the making
of any Federal loan, the entering into of any cooperative agreement, and the
extension, continuation, renewal, amendment or modification of any Federal
contract, grant, loan, or cooperative agreement;

(2)          If any funds other than Federal appropriated funds (including profit or
fee received under a covered Federal transaction) have been paid, or will be
paid, to any person for influencing or attempting to influence an officer or
employee of any agency, a Member of Congress, an officer or employee of
Congress, or an employee of a Member of Congress on his or

 

3

 

her behalf in connection with this solicitation, the offeror shall
complete and submit, with its offer, OMB standard form LLL, Disclosure of
Lobbying Activities, to the Contracting Officer; and

(3)          He or she will include the language of this certification in all
subcontract awards at any tier and require that all recipients of subcontract
awards in excess of $100,000 shall certify and disclose accordingly.

(c)          Submission of this certification and disclosure is a prerequisite for
making or entering into this contract imposed by section 1352, title 31, United
States Code. Any person who makes an expenditure prohibited under this
provision or who fails to file or amend the disclosure form to be filed or
amended by this provision shall be subject to a civil penalty of not less than
$10,000, and not more than $100,000, for each such failure.

(End of clause)

 

15.                               Intellectual Property (IP)

a.               The IP presented
in Attachment E represents the IP covering the technologies that the
Subcontractor contemplates for use under this Agreement.  The inventions covered by the listed patents
were produced in part with Federal funding. 
Therefore, except for the shaded line item in Attachment E that
represent non-Government funded inventions, the U.S. Government shall be
granted license to practice or have practiced for or on behalf of the United
States the subject invention or IP, in accordance with FAR Clause 52.227-11,
Patent Rights-Retention by the Contractor (JUN 97).

b.              With regard to the
shaded line items in Attachment E, which represent non-Government funded
inventions, the Subcontractor shall grant DVC, for the duration of this
Agreement, nonexclusive, non-transferable, irrevocable, paid-up licenses to
practice the subject inventions in
support of JVAP under U.S. Government Contract No. DAMD17-98-C-8024.

 

16.                               Agreement Changes

In
accordance with Clause No. 5, Changes, of Attachment A - DVC General Terms and
Conditions, DVC may modify this Agreement as required to accommodate scope,
schedule, and cost changes that may arise following its execution.

 

17.                               Special Provisions

None
identified.

 

 

IN WITNESS HEREOF, the parties have caused
this Agreement to be executed.

 

	
  Accepted for:

  	
   

  	
  Accepted for:

  
	
  Subcontractor

  	
   

  	
  DynPort Vaccine Company LLC

  
	
   

  	
   

  	
   

  
	
  Name:

  	
     Dr. Una S.
  Ryan

  	
   

  	
  Name:

  	
     Roy Conley

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Signature:

  	
     /s/ Una S.
  Ryan

  	
   

  	
  Signature:

  	
     /s/ Roy
  Conley

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Title:

  	
     President
  and CEO

  	
   

  	
  Title:

  	
     Senior Manager,
  Subcontracts

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Date:

  	
     January 15,
  2003

  	
   

  	
  Date:

  	
     January 15,
  2003

  
									

 

4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00057-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00057-of-00352.parquet"}]]